Background <p><i>Klebsiella pneumoniae</i> is a notoriously aggressive opportunistic pathogen within the <i>Enterobacteriaceae</i> family, with virulence factors, including polysaccharide capsules, lipopolysaccharide (LP&gt;S), siderophores, and biofilm formation, serving as essential determinants of the pathogenicity. Biofilms in particular are associated with substantial nosocomial and community-acquired illnesses; moreover, the capsule enveloping <i>K. pneumoniae’</i>s surface further contributes to its viscous phenotype and virulence. This study explores the possible anti-virulence properties of the plant-derived compound Rottlerin using molecular docking aimed at a crucial protein implicated in biofilm formation in <i>Klebsiella pneumoniae</i>. Here, we investigate the molecular foundation of ligand-specific modulation of MrkH, a c-di-GMP-responsive transcriptional activator essential for biofilm development in <i>Klebsiella pneumoniae</i>. Utilizing a comprehensive methodology that encompasses molecular docking, dynamic modeling, and structural analysis, we evaluated the native c-di-GMP dimer–MrkH complex against the binding orientation and conformational impacts of the plant-derived chemical Rottlerin.</p> Results <p>The sub-MIC of Rottlerin shows an inhibitory effect against some virulence factors, leading to a 57.6% decrease in biofilm formation, and a reduction in capsule size by 85.6% was observed; moreover, Rottlerin also significantly downregulated genes associated with these virulence factors. Through extensive molecular modeling (e.g., inverse docking, molecular dynamics simulation, and structural analysis), the c-di-GMP dimer was found to bind to rottlerin with a remarkable specificity, establishing stabilizing hydrogen bonds and distinctive π-cation interactions with Arg107 and Arg111, securing MrkH in an activation-ready configuration. Conversely, Rottlerin binds to the same pocket mainly via dual π-cation interactions with Arg107 and supplementary localized contacts; however, it is deficient in the extensive interaction network necessary for complete allosteric activation. Dynamic profiling by RMSF and PCA indicate that Rottlerin-bound MrkH exhibits an intermediate level of flexibility between the totally stable c-di-GMP-bound state and the highly dynamic apo form.</p> Conclusion <p>These results substantiate the function of Rottlerin as a non-activating competitive binder, providing mechanistic insight into its potential as an anti-biofilm agent and building a foundation for the rational design of small-molecule inhibitors aimed at c-di-GMP regulatory pathways. Our findings demonstrate that Rottlerin is a potent and efficient sub-MIC inhibitor of <i>K. pneumoniae</i>’s ability to form biofilms and capsules.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Mechanistic insights into Rottlerin’s inhibition of MrkH-mediated biofilm and capsule formation in Klebsiella pneumoniae

  • Rosette S. Hanna,
  • Mohamed Sebak,
  • Ahmed M. Sayed,
  • Ahmed O. El-Gendy,
  • Mostafa N. Taha

摘要

Background

Klebsiella pneumoniae is a notoriously aggressive opportunistic pathogen within the Enterobacteriaceae family, with virulence factors, including polysaccharide capsules, lipopolysaccharide (LP>S), siderophores, and biofilm formation, serving as essential determinants of the pathogenicity. Biofilms in particular are associated with substantial nosocomial and community-acquired illnesses; moreover, the capsule enveloping K. pneumoniae’s surface further contributes to its viscous phenotype and virulence. This study explores the possible anti-virulence properties of the plant-derived compound Rottlerin using molecular docking aimed at a crucial protein implicated in biofilm formation in Klebsiella pneumoniae. Here, we investigate the molecular foundation of ligand-specific modulation of MrkH, a c-di-GMP-responsive transcriptional activator essential for biofilm development in Klebsiella pneumoniae. Utilizing a comprehensive methodology that encompasses molecular docking, dynamic modeling, and structural analysis, we evaluated the native c-di-GMP dimer–MrkH complex against the binding orientation and conformational impacts of the plant-derived chemical Rottlerin.

Results

The sub-MIC of Rottlerin shows an inhibitory effect against some virulence factors, leading to a 57.6% decrease in biofilm formation, and a reduction in capsule size by 85.6% was observed; moreover, Rottlerin also significantly downregulated genes associated with these virulence factors. Through extensive molecular modeling (e.g., inverse docking, molecular dynamics simulation, and structural analysis), the c-di-GMP dimer was found to bind to rottlerin with a remarkable specificity, establishing stabilizing hydrogen bonds and distinctive π-cation interactions with Arg107 and Arg111, securing MrkH in an activation-ready configuration. Conversely, Rottlerin binds to the same pocket mainly via dual π-cation interactions with Arg107 and supplementary localized contacts; however, it is deficient in the extensive interaction network necessary for complete allosteric activation. Dynamic profiling by RMSF and PCA indicate that Rottlerin-bound MrkH exhibits an intermediate level of flexibility between the totally stable c-di-GMP-bound state and the highly dynamic apo form.

Conclusion

These results substantiate the function of Rottlerin as a non-activating competitive binder, providing mechanistic insight into its potential as an anti-biofilm agent and building a foundation for the rational design of small-molecule inhibitors aimed at c-di-GMP regulatory pathways. Our findings demonstrate that Rottlerin is a potent and efficient sub-MIC inhibitor of K. pneumoniae’s ability to form biofilms and capsules.